NovaBay Pharmaceuticals, Inc.(NYSE Amex Equities : NBY)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.26% | 203.42 | 1.3% | $752.26m | |
| GILD | Gilead Sciences, Inc. | 0.14% | 64.22 | 0.9% | $374.75m | |
| CELG | Celgene Corporation | 0.03% | 95.71 | 1.3% | $325.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 7.53% | 123.49 | 2.0% | $306.94m | |
| ILMN | Illumina, Inc. | -0.66% | 288.58 | 3.5% | $277.12m | |
| BIIB | Biogen Inc. | -0.48% | 232.06 | 1.3% | $268.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.16% | 184.24 | 1.9% | $256.63m | |
| EXAS | Exact Sciences Corporation | -1.14% | 117.87 | 24.1% | $239.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.93% | 295.02 | 2.6% | $203.40m | |
| A | Agilent Technologies, Inc. | -0.69% | 71.70 | 1.6% | $193.78m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.34% | 95.07 | 14.7% | $184.59m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.05% | 77.40 | 4.3% | $97.47m | |
| INCY | Incyte Corporation | -0.59% | 85.56 | 2.5% | $96.06m | |
| GHDX | Genomic Health, Inc. | -1.12% | 73.52 | 1.8% | $85.99m | |
| SGEN | Seattle Genetics, Inc. | -2.01% | 78.36 | 6.5% | $79.57m |
Company Profile
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.